| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Krueppel-associated box domain binding | 5.68e-06 | 3 | 28 | 2 | GO:0035851 | |
| GeneOntologyMolecularFunction | protein decrotonylase activity | 1.89e-05 | 5 | 28 | 2 | GO:0160008 | |
| GeneOntologyMolecularFunction | histone decrotonylase activity | 1.89e-05 | 5 | 28 | 2 | GO:0160009 | |
| GeneOntologyMolecularFunction | alpha-amylase activity | 1.89e-05 | 5 | 28 | 2 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 2.83e-05 | 6 | 28 | 2 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 2.25e-04 | 16 | 28 | 2 | GO:0031404 | |
| GeneOntologyMolecularFunction | histone deacetylase activity | 5.13e-04 | 24 | 28 | 2 | GO:0004407 | |
| GeneOntologyMolecularFunction | protein lysine deacetylase activity | 5.58e-04 | 25 | 28 | 2 | GO:0033558 | |
| GeneOntologyMolecularFunction | NF-kappaB binding | 1.16e-03 | 36 | 28 | 2 | GO:0051059 | |
| GeneOntologyMolecularFunction | deacetylase activity | 1.43e-03 | 40 | 28 | 2 | GO:0019213 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 3.09e-03 | 59 | 28 | 2 | GO:0001222 | |
| GeneOntologyMolecularFunction | calcium ion binding | 3.51e-03 | 749 | 28 | 5 | GO:0005509 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 3.96e-03 | 67 | 28 | 2 | GO:0031492 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 5.74e-03 | 81 | 28 | 2 | GO:0016811 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 6.02e-03 | 83 | 28 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | nucleosome binding | 8.29e-03 | 98 | 28 | 2 | GO:0031491 | |
| GeneOntologyBiologicalProcess | fungiform papilla formation | 9.89e-06 | 4 | 27 | 2 | GO:0061198 | |
| GeneOntologyBiologicalProcess | hair follicle placode formation | 2.47e-05 | 6 | 27 | 2 | GO:0060789 | |
| GeneOntologyBiologicalProcess | fungiform papilla morphogenesis | 2.47e-05 | 6 | 27 | 2 | GO:0061197 | |
| GeneOntologyBiologicalProcess | fungiform papilla development | 3.45e-05 | 7 | 27 | 2 | GO:0061196 | |
| GeneOntologyBiologicalProcess | tongue morphogenesis | 1.08e-04 | 12 | 27 | 2 | GO:0043587 | |
| GeneOntologyBiologicalProcess | embryonic digit morphogenesis | 1.22e-04 | 74 | 27 | 3 | GO:0042733 | |
| GeneOntologyBiologicalProcess | limb development | 1.95e-04 | 224 | 27 | 4 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 1.95e-04 | 224 | 27 | 4 | GO:0048736 | |
| GeneOntologyBiologicalProcess | ectodermal placode morphogenesis | 1.96e-04 | 16 | 27 | 2 | GO:0071697 | |
| GeneOntologyBiologicalProcess | eyelid development in camera-type eye | 1.96e-04 | 16 | 27 | 2 | GO:0061029 | |
| GeneOntologyBiologicalProcess | ectodermal placode formation | 1.96e-04 | 16 | 27 | 2 | GO:0060788 | |
| GeneOntologyBiologicalProcess | ectodermal placode development | 2.49e-04 | 18 | 27 | 2 | GO:0071696 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell population maintenance | 5.26e-04 | 26 | 27 | 2 | GO:1902455 | |
| GeneOntologyBiologicalProcess | tongue development | 5.68e-04 | 27 | 27 | 2 | GO:0043586 | |
| GeneOntologyBiologicalProcess | regulation of signaling receptor activity | 6.55e-04 | 131 | 27 | 3 | GO:0010469 | |
| GeneOntologyBiologicalProcess | regulation of cell fate specification | 6.56e-04 | 29 | 27 | 2 | GO:0042659 | |
| GeneOntologyBiologicalProcess | oligodendrocyte differentiation | 7.46e-04 | 137 | 27 | 3 | GO:0048709 | |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta receptor signaling pathway | 7.62e-04 | 138 | 27 | 3 | GO:0030512 | |
| GeneOntologyBiologicalProcess | positive regulation of signaling receptor activity | 8.50e-04 | 33 | 27 | 2 | GO:2000273 | |
| GeneOntologyBiologicalProcess | positive regulation of oligodendrocyte differentiation | 9.02e-04 | 34 | 27 | 2 | GO:0048714 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 9.33e-04 | 148 | 27 | 3 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 9.33e-04 | 148 | 27 | 3 | GO:0035113 | |
| GeneOntologyBiologicalProcess | odontogenesis | 9.89e-04 | 151 | 27 | 3 | GO:0042476 | |
| GeneOntologyCellularComponent | NuRD complex | 2.32e-04 | 17 | 28 | 2 | GO:0016581 | |
| GeneOntologyCellularComponent | CHD-type complex | 2.32e-04 | 17 | 28 | 2 | GO:0090545 | |
| GeneOntologyCellularComponent | Sin3-type complex | 3.93e-04 | 22 | 28 | 2 | GO:0070822 | |
| Domain | A-amylase_C | 6.50e-06 | 3 | 28 | 2 | IPR031319 | |
| Domain | His_deacetylse_1 | 1.30e-05 | 4 | 28 | 2 | IPR003084 | |
| Domain | Aamy_C | 1.30e-05 | 4 | 28 | 2 | SM00632 | |
| Domain | Alpha_amylase | 1.30e-05 | 4 | 28 | 2 | IPR006046 | |
| Domain | Alpha-amylase_C | 2.16e-05 | 5 | 28 | 2 | PF02806 | |
| Domain | A-amylase/branching_C | 2.16e-05 | 5 | 28 | 2 | IPR006048 | |
| Domain | Glyco_hydro_13 | 3.24e-05 | 6 | 28 | 2 | IPR015902 | |
| Domain | Aamy | 4.53e-05 | 7 | 28 | 2 | SM00642 | |
| Domain | Alpha-amylase | 4.53e-05 | 7 | 28 | 2 | PF00128 | |
| Domain | Glyco_hydro_13_cat_dom | 4.53e-05 | 7 | 28 | 2 | IPR006047 | |
| Domain | His_deacetylse_dom | 1.18e-04 | 11 | 28 | 2 | IPR023801 | |
| Domain | Hist_deacetyl | 1.18e-04 | 11 | 28 | 2 | PF00850 | |
| Domain | - | 1.18e-04 | 11 | 28 | 2 | 3.40.800.20 | |
| Domain | His_deacetylse | 1.18e-04 | 11 | 28 | 2 | IPR000286 | |
| Domain | - | 1.95e-04 | 14 | 28 | 2 | 2.60.40.1180 | |
| Domain | Glyco_hydro_b | 2.25e-04 | 15 | 28 | 2 | IPR013780 | |
| Domain | - | 1.25e-03 | 35 | 28 | 2 | 3.20.20.80 | |
| Domain | Glyco_hydro_catalytic_dom | 1.47e-03 | 38 | 28 | 2 | IPR013781 | |
| Domain | Glycoside_hydrolase_SF | 2.85e-03 | 53 | 28 | 2 | IPR017853 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 2.54e-05 | 5 | 23 | 2 | MM15874 | |
| Pathway | REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1 | 3.80e-05 | 6 | 23 | 2 | M27072 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_REST_MEDIATED_TRANSCRIPTIONAL_REPRESSION | 5.32e-05 | 7 | 23 | 2 | M47673 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 6.25e-05 | 48 | 23 | 3 | M219 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 7.09e-05 | 8 | 23 | 2 | MM14717 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 9.10e-05 | 9 | 23 | 2 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.39e-04 | 11 | 23 | 2 | M1091 | |
| Pathway | KEGG_MEDICUS_VARIANT_TEL_AML1_FUSION_TO_TRANSCRIPTIONAL_REPRESSION | 1.39e-04 | 11 | 23 | 2 | M47438 | |
| Pathway | REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING | 1.39e-04 | 11 | 23 | 2 | M42523 | |
| Pathway | KEGG_CHRONIC_MYELOID_LEUKEMIA | 2.19e-04 | 73 | 23 | 3 | M321 | |
| Pathway | BIOCARTA_PRC2_PATHWAY | 2.29e-04 | 14 | 23 | 2 | M22025 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 3.83e-04 | 18 | 23 | 2 | M5290 | |
| Pathway | REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS | 3.83e-04 | 18 | 23 | 2 | M27901 | |
| Pathway | WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS | 4.75e-04 | 20 | 23 | 2 | M48330 | |
| Pathway | REACTOME_DIGESTION | 5.25e-04 | 21 | 23 | 2 | MM15526 | |
| Pathway | REACTOME_DIGESTION | 6.31e-04 | 23 | 23 | 2 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 7.47e-04 | 25 | 23 | 2 | MM15557 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 8.08e-04 | 26 | 23 | 2 | M2499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES | 8.72e-04 | 27 | 23 | 2 | M47941 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 9.38e-04 | 28 | 23 | 2 | M27837 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 9.38e-04 | 28 | 23 | 2 | M6177 | |
| Pathway | BIOCARTA_G1_PATHWAY | 9.38e-04 | 28 | 23 | 2 | M648 | |
| Pathway | WP_CELL_CYCLE | 9.41e-04 | 120 | 23 | 3 | M39650 | |
| Pathway | KEGG_CELL_CYCLE | 1.06e-03 | 125 | 23 | 3 | M7963 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 1.08e-03 | 30 | 23 | 2 | M27637 | |
| Pathway | REACTOME_SIGNALING_BY_ALK | 1.08e-03 | 30 | 23 | 2 | M42517 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES | 1.08e-03 | 30 | 23 | 2 | M27941 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION | 1.15e-03 | 31 | 23 | 2 | M48258 | |
| Pathway | WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS | 1.15e-03 | 31 | 23 | 2 | M39714 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.23e-03 | 32 | 23 | 2 | M39521 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 1.23e-03 | 32 | 23 | 2 | M27900 | |
| Pathway | WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA | 1.64e-03 | 37 | 23 | 2 | M39756 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 1.79e-03 | 150 | 23 | 3 | M27440 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.42e-03 | 45 | 23 | 2 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.52e-03 | 46 | 23 | 2 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.63e-03 | 47 | 23 | 2 | M7946 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION | 2.63e-03 | 47 | 23 | 2 | M1095 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.74e-03 | 48 | 23 | 2 | M611 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 3.21e-03 | 52 | 23 | 2 | M14171 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 3.98e-03 | 58 | 23 | 2 | M29616 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 4.40e-03 | 61 | 23 | 2 | M39540 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 4.40e-03 | 61 | 23 | 2 | M27811 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 4.68e-03 | 63 | 23 | 2 | M27862 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 4.81e-03 | 431 | 23 | 4 | M39729 | |
| Pathway | WP_CILIARY_LANDSCAPE | 4.95e-03 | 215 | 23 | 3 | M39734 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 5.13e-03 | 66 | 23 | 2 | M101 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 5.13e-03 | 66 | 23 | 2 | M27938 | |
| Pathway | PID_TELOMERASE_PATHWAY | 5.28e-03 | 67 | 23 | 2 | M105 | |
| Pubmed | 1.63e-08 | 7 | 28 | 3 | 6160178 | ||
| Pubmed | Histone deacetylases 1 and 2 regulate autophagy flux and skeletal muscle homeostasis in mice. | 6.25e-07 | 2 | 28 | 2 | 22307625 | |
| Pubmed | The action of human pancreatic and salivary isoamylases on starch and glycogen. | 6.25e-07 | 2 | 28 | 2 | 890964 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 35575026 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 26116233 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 23792463 | ||
| Pubmed | Dynamic distribution of HDAC1 and HDAC2 during mitosis: association with F-actin. | 6.25e-07 | 2 | 28 | 2 | 23280436 | |
| Pubmed | Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL. | 6.25e-07 | 2 | 28 | 2 | 25688158 | |
| Pubmed | Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts. | 6.25e-07 | 2 | 28 | 2 | 19531758 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 23516383 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 19740981 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 10904264 | ||
| Pubmed | HDAC1 and HDAC2 collectively regulate intestinal stem cell homeostasis. | 6.25e-07 | 2 | 28 | 2 | 25648995 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 31222845 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 24525021 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 11376382 | ||
| Pubmed | Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. | 6.25e-07 | 2 | 28 | 2 | 17639084 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 11287668 | ||
| Pubmed | Differential HDAC1/2 network analysis reveals a role for prefoldin/CCT in HDAC1/2 complex assembly. | 6.25e-07 | 2 | 28 | 2 | 30209338 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 31533525 | ||
| Pubmed | HDAC1 and HDAC2 are differentially expressed in endometriosis. | 6.25e-07 | 2 | 28 | 2 | 22344732 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 34890513 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 32366868 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 21423190 | ||
| Pubmed | HDAC1 and HDAC2 independently regulate common and specific intrinsic responses in murine enteroids. | 6.25e-07 | 2 | 28 | 2 | 30926862 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 24335310 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 38523117 | ||
| Pubmed | Trans-regulation of histone deacetylase activities through acetylation. | 6.25e-07 | 2 | 28 | 2 | 19822520 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 18408217 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 31692265 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 28579617 | ||
| Pubmed | HDAC1 and HDAC2 Modulate TGF-β Signaling during Endothelial-to-Hematopoietic Transition. | 6.25e-07 | 2 | 28 | 2 | 29641990 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 24040068 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 26174178 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 15297431 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 25270209 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 24958871 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 22156779 | ||
| Pubmed | Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer. | 6.25e-07 | 2 | 28 | 2 | 20585871 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 26129908 | ||
| Pubmed | Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation. | 6.25e-07 | 2 | 28 | 2 | 19412887 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 19561124 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 3260028 | ||
| Pubmed | The human amylase-encoding genes amy2 and amy3 are identical to AMY2A and AMY2B. | 6.25e-07 | 2 | 28 | 2 | 2483397 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 26352599 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 22416134 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 23251689 | ||
| Pubmed | Histone deacetylase HDA-1 modulates mitochondrial stress response and longevity. | 6.25e-07 | 2 | 28 | 2 | 32934238 | |
| Pubmed | Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. | 6.25e-07 | 2 | 28 | 2 | 20802485 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 22037263 | ||
| Pubmed | Loss of histone deacetylase 2 improves working memory and accelerates extinction learning. | 6.25e-07 | 2 | 28 | 2 | 23575838 | |
| Pubmed | Inhibition of histone deacetylase 1 (HDAC1) and HDAC2 enhances CRISPR/Cas9 genome editing. | 6.25e-07 | 2 | 28 | 2 | 31799598 | |
| Pubmed | Podocyte histone deacetylase activity regulates murine and human glomerular diseases. | 6.25e-07 | 2 | 28 | 2 | 30776024 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 15016876 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 21270520 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 11919195 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 21292776 | ||
| Pubmed | Genetic dissection of histone deacetylase requirement in tumor cells. | 6.25e-07 | 2 | 28 | 2 | 19416910 | |
| Pubmed | Human pancreatic alpha-amylase: phenotypic codominance and new electrophoretic variants. | 6.25e-07 | 2 | 28 | 2 | 309725 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 23287868 | ||
| Pubmed | HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer. | 6.25e-07 | 2 | 28 | 2 | 30669676 | |
| Pubmed | HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells. | 6.25e-07 | 2 | 28 | 2 | 31071955 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 33498747 | ||
| Pubmed | Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy. | 6.25e-07 | 2 | 28 | 2 | 21725353 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 25942572 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 36346011 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 19553468 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 24449838 | ||
| Pubmed | HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells. | 6.25e-07 | 2 | 28 | 2 | 20398369 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 23744762 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 30279482 | ||
| Pubmed | HDAC1/2 and HDAC3 play distinct roles in controlling adult Meibomian gland homeostasis. | 1.87e-06 | 3 | 28 | 2 | 38679196 | |
| Pubmed | Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. | 1.87e-06 | 3 | 28 | 2 | 21367693 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 18172012 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 24763403 | ||
| Pubmed | Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2. | 1.87e-06 | 3 | 28 | 2 | 27635759 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 32015101 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 23835259 | ||
| Pubmed | Retinoic acid and histone deacetylases regulate epigenetic changes in embryonic stem cells. | 1.87e-06 | 3 | 28 | 2 | 24821725 | |
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 1.87e-06 | 3 | 28 | 2 | 2413838 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 6098446 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 22223663 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 18501342 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 28139683 | ||
| Pubmed | PML-RARalpha alleviates the transcriptional repression mediated by tumor suppressor Rb. | 1.87e-06 | 3 | 28 | 2 | 11583987 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 23612983 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 2414282 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 8917507 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 38254102 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 21511710 | ||
| Pubmed | Cell Cycle and Senescence Regulation by Podocyte Histone Deacetylase 1 and 2. | 1.87e-06 | 3 | 28 | 2 | 36414418 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 25808664 | ||
| Pubmed | Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer. | 1.87e-06 | 3 | 28 | 2 | 19099586 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 27668390 | ||
| Pubmed | A DNMT3A2-HDAC2 Complex Is Essential for Genomic Imprinting and Genome Integrity in Mouse Oocytes. | 1.87e-06 | 3 | 28 | 2 | 26586441 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 18212746 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 11564889 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 8413315 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 29472538 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 34203519 | ||
| Interaction | NCAPG interactions | 6.50e-06 | 202 | 27 | 5 | int:NCAPG | |
| Interaction | SLFN11 interactions | 8.61e-06 | 376 | 27 | 6 | int:SLFN11 | |
| Interaction | NCAPD2 interactions | 1.33e-05 | 234 | 27 | 5 | int:NCAPD2 | |
| Interaction | C22orf31 interactions | 1.72e-05 | 5 | 27 | 2 | int:C22orf31 | |
| Interaction | SMC4 interactions | 3.19e-05 | 281 | 27 | 5 | int:SMC4 | |
| Interaction | FLII interactions | 4.23e-05 | 298 | 27 | 5 | int:FLII | |
| Interaction | EFCAB6 interactions | 4.82e-05 | 8 | 27 | 2 | int:EFCAB6 | |
| Interaction | SNAI3 interactions | 4.82e-05 | 8 | 27 | 2 | int:SNAI3 | |
| Interaction | KPNA2 interactions | 5.29e-05 | 519 | 27 | 6 | int:KPNA2 | |
| Interaction | MCCC2 interactions | 6.11e-05 | 162 | 27 | 4 | int:MCCC2 | |
| Interaction | DNAJA1 interactions | 6.14e-05 | 533 | 27 | 6 | int:DNAJA1 | |
| Interaction | HFM1 interactions | 6.19e-05 | 9 | 27 | 2 | int:HFM1 | |
| Interaction | SMC2 interactions | 6.19e-05 | 323 | 27 | 5 | int:SMC2 | |
| Interaction | AMY2B interactions | 7.73e-05 | 10 | 27 | 2 | int:AMY2B | |
| Interaction | NUP50 interactions | 8.00e-05 | 341 | 27 | 5 | int:NUP50 | |
| Interaction | RFC2 interactions | 8.07e-05 | 174 | 27 | 4 | int:RFC2 | |
| Interaction | PPP4R3A interactions | 9.00e-05 | 179 | 27 | 4 | int:PPP4R3A | |
| Interaction | RBBP4 interactions | 9.15e-05 | 573 | 27 | 6 | int:RBBP4 | |
| Interaction | KPNA1 interactions | 9.17e-05 | 351 | 27 | 5 | int:KPNA1 | |
| Interaction | PSMD11 interactions | 9.42e-05 | 353 | 27 | 5 | int:PSMD11 | |
| Interaction | MYH10 interactions | 1.02e-04 | 359 | 27 | 5 | int:MYH10 | |
| Interaction | MCCC1 interactions | 1.07e-04 | 187 | 27 | 4 | int:MCCC1 | |
| Interaction | OVOL1 interactions | 1.13e-04 | 12 | 27 | 2 | int:OVOL1 | |
| Interaction | PSMC1 interactions | 1.15e-04 | 368 | 27 | 5 | int:PSMC1 | |
| Interaction | CCDC71 interactions | 1.20e-04 | 72 | 27 | 3 | int:CCDC71 | |
| Interaction | ZNF843 interactions | 1.56e-04 | 14 | 27 | 2 | int:ZNF843 | |
| Interaction | IPO5 interactions | 1.99e-04 | 414 | 27 | 5 | int:IPO5 | |
| Interaction | RFC1 interactions | 2.40e-04 | 231 | 27 | 4 | int:RFC1 | |
| Interaction | ATF3 interactions | 2.65e-04 | 94 | 27 | 3 | int:ATF3 | |
| Interaction | BRMS1 interactions | 2.82e-04 | 96 | 27 | 3 | int:BRMS1 | |
| Interaction | GRIP1 interactions | 2.82e-04 | 96 | 27 | 3 | int:GRIP1 | |
| Interaction | H2BC14 interactions | 3.18e-04 | 100 | 27 | 3 | int:H2BC14 | |
| Interaction | HOXA11 interactions | 3.57e-04 | 21 | 27 | 2 | int:HOXA11 | |
| Interaction | AMY2A interactions | 3.57e-04 | 21 | 27 | 2 | int:AMY2A | |
| Interaction | PPP6R3 interactions | 3.65e-04 | 258 | 27 | 4 | int:PPP6R3 | |
| Interaction | ZFPM1 interactions | 3.93e-04 | 22 | 27 | 2 | int:ZFPM1 | |
| Interaction | SPAG9 interactions | 4.22e-04 | 268 | 27 | 4 | int:SPAG9 | |
| Interaction | MIER3 interactions | 4.30e-04 | 23 | 27 | 2 | int:MIER3 | |
| Interaction | PHF21B interactions | 4.30e-04 | 23 | 27 | 2 | int:PHF21B | |
| Interaction | MSH6 interactions | 4.40e-04 | 271 | 27 | 4 | int:MSH6 | |
| Interaction | RCOR1 interactions | 4.48e-04 | 494 | 27 | 5 | int:RCOR1 | |
| Interaction | H3C3 interactions | 4.52e-04 | 495 | 27 | 5 | int:H3C3 | |
| Interaction | EID2 interactions | 4.68e-04 | 24 | 27 | 2 | int:EID2 | |
| Interaction | GFI1 interactions | 4.68e-04 | 24 | 27 | 2 | int:GFI1 | |
| Interaction | BOC interactions | 4.68e-04 | 24 | 27 | 2 | int:BOC | |
| Interaction | HDAC1 interactions | 5.01e-04 | 1108 | 27 | 7 | int:HDAC1 | |
| Interaction | IKZF2 interactions | 5.51e-04 | 26 | 27 | 2 | int:IKZF2 | |
| Interaction | PDX1 interactions | 5.51e-04 | 26 | 27 | 2 | int:PDX1 | |
| Interaction | ACTL6A interactions | 5.60e-04 | 289 | 27 | 4 | int:ACTL6A | |
| Interaction | ZFPM2 interactions | 6.39e-04 | 28 | 27 | 2 | int:ZFPM2 | |
| Interaction | H2AJ interactions | 6.40e-04 | 127 | 27 | 3 | int:H2AJ | |
| Interaction | ZNF827 interactions | 6.86e-04 | 29 | 27 | 2 | int:ZNF827 | |
| Interaction | KPNB1 interactions | 6.94e-04 | 544 | 27 | 5 | int:KPNB1 | |
| Interaction | SENP1 interactions | 7.00e-04 | 131 | 27 | 3 | int:SENP1 | |
| Interaction | NONO interactions | 7.24e-04 | 549 | 27 | 5 | int:NONO | |
| Interaction | IFT74 interactions | 7.32e-04 | 133 | 27 | 3 | int:IFT74 | |
| Interaction | ESCO1 interactions | 7.35e-04 | 30 | 27 | 2 | int:ESCO1 | |
| Interaction | GYG2 interactions | 7.35e-04 | 30 | 27 | 2 | int:GYG2 | |
| Interaction | NCAPH interactions | 7.74e-04 | 315 | 27 | 4 | int:NCAPH | |
| Interaction | ZMYM3 interactions | 7.98e-04 | 137 | 27 | 3 | int:ZMYM3 | |
| Interaction | EML4 interactions | 7.98e-04 | 137 | 27 | 3 | int:EML4 | |
| Interaction | KDM5C interactions | 8.32e-04 | 139 | 27 | 3 | int:KDM5C | |
| Interaction | HDAC2 interactions | 8.38e-04 | 865 | 27 | 6 | int:HDAC2 | |
| Interaction | PPP1R12A interactions | 8.40e-04 | 322 | 27 | 4 | int:PPP1R12A | |
| Interaction | NUP88 interactions | 8.49e-04 | 140 | 27 | 3 | int:NUP88 | |
| Interaction | DENND4C interactions | 8.49e-04 | 140 | 27 | 3 | int:DENND4C | |
| Interaction | SAP30L interactions | 8.90e-04 | 33 | 27 | 2 | int:SAP30L | |
| Interaction | DCTN4 interactions | 9.03e-04 | 143 | 27 | 3 | int:DCTN4 | |
| Interaction | DNAJC13 interactions | 9.03e-04 | 143 | 27 | 3 | int:DNAJC13 | |
| Interaction | DELEC1 interactions | 9.44e-04 | 34 | 27 | 2 | int:DELEC1 | |
| Interaction | TNFSF10 interactions | 1.00e-03 | 35 | 27 | 2 | int:TNFSF10 | |
| Interaction | TGIF2LX interactions | 1.06e-03 | 36 | 27 | 2 | int:TGIF2LX | |
| Interaction | RAB3GAP2 interactions | 1.08e-03 | 152 | 27 | 3 | int:RAB3GAP2 | |
| Interaction | LRRFIP1 interactions | 1.10e-03 | 153 | 27 | 3 | int:LRRFIP1 | |
| Interaction | CCDC174 interactions | 1.12e-03 | 37 | 27 | 2 | int:CCDC174 | |
| Interaction | MAFK interactions | 1.12e-03 | 37 | 27 | 2 | int:MAFK | |
| Interaction | AKR1C3 interactions | 1.12e-03 | 37 | 27 | 2 | int:AKR1C3 | |
| Interaction | MIER2 interactions | 1.12e-03 | 37 | 27 | 2 | int:MIER2 | |
| Interaction | PADI4 interactions | 1.12e-03 | 37 | 27 | 2 | int:PADI4 | |
| Interaction | BAZ1A interactions | 1.16e-03 | 156 | 27 | 3 | int:BAZ1A | |
| Interaction | CPVL interactions | 1.16e-03 | 156 | 27 | 3 | int:CPVL | |
| Interaction | NR2E1 interactions | 1.18e-03 | 38 | 27 | 2 | int:NR2E1 | |
| Interaction | SMARCC2 interactions | 1.18e-03 | 353 | 27 | 4 | int:SMARCC2 | |
| Interaction | PRMT1 interactions | 1.21e-03 | 929 | 27 | 6 | int:PRMT1 | |
| Interaction | KAT5 interactions | 1.24e-03 | 358 | 27 | 4 | int:KAT5 | |
| Interaction | C9orf78 interactions | 1.25e-03 | 620 | 27 | 5 | int:C9orf78 | |
| Interaction | MBD2 interactions | 1.27e-03 | 161 | 27 | 3 | int:MBD2 | |
| Interaction | TMOD1 interactions | 1.27e-03 | 161 | 27 | 3 | int:TMOD1 | |
| Interaction | POLR3A interactions | 1.32e-03 | 163 | 27 | 3 | int:POLR3A | |
| Interaction | ALDH1A2 interactions | 1.37e-03 | 41 | 27 | 2 | int:ALDH1A2 | |
| Interaction | TGIF1 interactions | 1.37e-03 | 41 | 27 | 2 | int:TGIF1 | |
| Interaction | PPM1E interactions | 1.37e-03 | 41 | 27 | 2 | int:PPM1E | |
| Interaction | ZNF521 interactions | 1.37e-03 | 41 | 27 | 2 | int:ZNF521 | |
| Interaction | MBD3L2 interactions | 1.37e-03 | 41 | 27 | 2 | int:MBD3L2 | |
| Interaction | PARP1 interactions | 1.39e-03 | 1316 | 27 | 7 | int:PARP1 | |
| Interaction | SNRNP40 interactions | 1.41e-03 | 637 | 27 | 5 | int:SNRNP40 | |
| Interaction | MORF4L2 interactions | 1.44e-03 | 168 | 27 | 3 | int:MORF4L2 | |
| Interaction | IFRD1 interactions | 1.44e-03 | 42 | 27 | 2 | int:IFRD1 | |
| Interaction | JDP2 interactions | 1.44e-03 | 42 | 27 | 2 | int:JDP2 | |
| Interaction | RBP1 interactions | 1.44e-03 | 42 | 27 | 2 | int:RBP1 | |
| Cytoband | 1p21 | 9.82e-05 | 24 | 28 | 2 | 1p21 | |
| Cytoband | 1p13.3 | 8.21e-04 | 69 | 28 | 2 | 1p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 1.96e-03 | 107 | 28 | 2 | chr1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | 3.74e-03 | 149 | 28 | 2 | chr17q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 7.35e-03 | 211 | 28 | 2 | chr1p13 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 4.99e-06 | 4 | 17 | 2 | 989 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 2.98e-05 | 9 | 17 | 2 | 1306 | |
| GeneFamily | PHD finger proteins|NuRD complex | 5.46e-05 | 12 | 17 | 2 | 1305 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 5.46e-05 | 12 | 17 | 2 | 1243 | |
| GeneFamily | Fibronectin type III domain containing | 9.70e-03 | 160 | 17 | 2 | 555 | |
| GeneFamily | EF-hand domain containing | 1.76e-02 | 219 | 17 | 2 | 863 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.69e-05 | 164 | 28 | 4 | M9106 | |
| Coexpression | GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN | 5.72e-05 | 199 | 28 | 4 | M4142 | |
| Coexpression | BERGER_MBD2_TARGETS | 6.02e-05 | 11 | 28 | 2 | MM905 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_UP | 7.45e-05 | 213 | 28 | 4 | M14601 | |
| Drug | AC1L1EA5 | 1.91e-08 | 24 | 28 | 4 | CID000002706 | |
| Drug | allylsilane | 8.74e-06 | 4 | 28 | 2 | CID000140349 | |
| Drug | Vorinostat | 1.46e-05 | 5 | 28 | 2 | DB02546 | |
| Drug | S-p-nitrobenzyloxycarbonylglutathione | 1.48e-05 | 39 | 28 | 3 | CID004632704 | |
| Drug | ammonium sulfate | 1.65e-05 | 126 | 28 | 4 | CID000024538 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 2.18e-05 | 6 | 28 | 2 | CID003083414 | |
| Drug | CNP-G3 | 2.18e-05 | 6 | 28 | 2 | CID003082910 | |
| Drug | R 623 | 2.18e-05 | 6 | 28 | 2 | CID003027594 | |
| Drug | dimethylaminomethylferrocene | 2.18e-05 | 6 | 28 | 2 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 2.18e-05 | 6 | 28 | 2 | CID000127364 | |
| Drug | kasugamycin | 2.60e-05 | 47 | 28 | 3 | CID000065174 | |
| Drug | BG5P | 3.05e-05 | 7 | 28 | 2 | CID003082752 | |
| Drug | AC1L5BOU | 3.05e-05 | 7 | 28 | 2 | CID000174858 | |
| Drug | 6-O-methylglucose | 3.05e-05 | 7 | 28 | 2 | CID000151009 | |
| Drug | Alfadexum | 3.96e-05 | 54 | 28 | 3 | CID000024796 | |
| Drug | desethylaprophen | 4.07e-05 | 8 | 28 | 2 | CID000163919 | |
| Drug | azintamide | 4.07e-05 | 8 | 28 | 2 | CID000071105 | |
| Drug | DB08184 | 4.98e-05 | 167 | 28 | 4 | CID009547945 | |
| Drug | ginsenoside Rh2 | 5.22e-05 | 9 | 28 | 2 | ctd:C055305 | |
| Drug | alpha-maltosyl fluoride | 5.22e-05 | 9 | 28 | 2 | CID000194237 | |
| Drug | trestatin A | 5.22e-05 | 9 | 28 | 2 | CID003054994 | |
| Drug | AC1LAC07 | 6.52e-05 | 10 | 28 | 2 | CID000485275 | |
| Drug | AC1L3M0Q | 6.52e-05 | 10 | 28 | 2 | CID000118008 | |
| Drug | acetylhypofluorite | 6.52e-05 | 10 | 28 | 2 | CID000127602 | |
| Drug | Glc)4 | 6.52e-05 | 10 | 28 | 2 | CID000189098 | |
| Drug | CI-994 | 6.52e-05 | 10 | 28 | 2 | CID000002746 | |
| Drug | Ro 20-0083 | 6.52e-05 | 10 | 28 | 2 | CID003082332 | |
| Drug | validamycin D | 7.97e-05 | 11 | 28 | 2 | CID000166726 | |
| Drug | N-methylpyrrole | 7.97e-05 | 11 | 28 | 2 | CID000007304 | |
| Drug | HgI2 | 7.97e-05 | 11 | 28 | 2 | CID000024485 | |
| Drug | 2C KM | 7.97e-05 | 11 | 28 | 2 | CID009549196 | |
| Drug | FG5P | 7.97e-05 | 11 | 28 | 2 | CID000127486 | |
| Drug | CNP-G5 | 7.97e-05 | 11 | 28 | 2 | CID000127309 | |
| Drug | azaprophen | 9.55e-05 | 12 | 28 | 2 | CID000129486 | |
| Drug | 1-adamantaneacetic acid | 9.55e-05 | 12 | 28 | 2 | CID000123221 | |
| Drug | methyl 1'-epiacarviosin | 1.13e-04 | 13 | 28 | 2 | CID000197426 | |
| Drug | isoacarbose | 1.13e-04 | 13 | 28 | 2 | CID000449165 | |
| Drug | 8a-c | 1.13e-04 | 13 | 28 | 2 | CID000066085 | |
| Drug | sodium methoxide | 1.32e-04 | 14 | 28 | 2 | CID010942334 | |
| Drug | Cyclodextrins | 1.32e-04 | 14 | 28 | 2 | CID000024238 | |
| Drug | terephthaloyl chloride | 1.32e-04 | 14 | 28 | 2 | CID000007488 | |
| Drug | 2-chloro-4-nitrophenol | 1.32e-04 | 14 | 28 | 2 | CID000012074 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.43e-04 | 83 | 28 | 3 | CID011968896 | |
| Drug | butyl methacrylate | 1.52e-04 | 15 | 28 | 2 | CID000007354 | |
| Drug | nafadotride | 1.52e-04 | 15 | 28 | 2 | CID003408722 | |
| Drug | 4-nitrophenylmaltoheptaoside | 1.52e-04 | 15 | 28 | 2 | CID000173254 | |
| Drug | formamide | 1.54e-04 | 85 | 28 | 3 | CID000000713 | |
| Drug | AC1NV99J | 1.73e-04 | 16 | 28 | 2 | CID005474719 | |
| Drug | gamma-cyclodextrin | 1.73e-04 | 16 | 28 | 2 | CID000086575 | |
| Drug | Bay e 4609 | 1.73e-04 | 16 | 28 | 2 | CID003085308 | |
| Drug | polyphenon E | 1.96e-04 | 17 | 28 | 2 | ctd:C472086 | |
| Drug | Rodeo | 1.96e-04 | 17 | 28 | 2 | CID000038078 | |
| Drug | trimitan | 2.20e-04 | 18 | 28 | 2 | CID000005561 | |
| Drug | AC1L1EXH | 2.20e-04 | 18 | 28 | 2 | CID000002992 | |
| Drug | aprophen | 2.20e-04 | 18 | 28 | 2 | CID000071128 | |
| Drug | Lugol's iodine | 2.46e-04 | 19 | 28 | 2 | CID000105053 | |
| Drug | NSC3852 | 2.73e-04 | 20 | 28 | 2 | CID000019103 | |
| Drug | AC1L3XPY | 3.02e-04 | 21 | 28 | 2 | CID000124005 | |
| Drug | 1,8-diazabicycloundec-7-ene | 3.32e-04 | 22 | 28 | 2 | CID000081184 | |
| Drug | NSC-1905 | 3.32e-04 | 22 | 28 | 2 | CID003816245 | |
| Drug | AC1L1QCE | 3.32e-04 | 22 | 28 | 2 | CID000008135 | |
| Drug | maltosaccharide | 3.32e-04 | 22 | 28 | 2 | CID005461034 | |
| Drug | Panose B | 3.96e-04 | 24 | 28 | 2 | CID000439297 | |
| Drug | CID439354 | 4.30e-04 | 25 | 28 | 2 | CID000439354 | |
| Drug | UF010 compound | 4.30e-04 | 25 | 28 | 2 | ctd:C000602704 | |
| Drug | NSC24559 | 4.46e-04 | 122 | 28 | 3 | CID000029051 | |
| Drug | hydroxycitrate | 4.65e-04 | 26 | 28 | 2 | CID000123908 | |
| Drug | cupric oxide | 4.73e-04 | 543 | 28 | 5 | ctd:C030973 | |
| Drug | y BT | 5.02e-04 | 27 | 28 | 2 | CID000447121 | |
| Drug | dl-cystine | 5.13e-04 | 128 | 28 | 3 | CID000000595 | |
| Drug | decanoate | 5.49e-04 | 131 | 28 | 3 | CID000002969 | |
| Drug | trimethylphosphine | 6.21e-04 | 30 | 28 | 2 | CID000068983 | |
| Drug | N,N'-disalicylidene-1,3-diaminopropane | 6.21e-04 | 30 | 28 | 2 | CID005373003 | |
| Drug | dinoseb | 6.21e-04 | 30 | 28 | 2 | CID000006950 | |
| Drug | beta-propiolactone | 7.07e-04 | 32 | 28 | 2 | CID000002365 | |
| Drug | Folin Marenzi reagent | 7.07e-04 | 32 | 28 | 2 | CID000452313 | |
| Drug | AC1L1G8B | 7.07e-04 | 32 | 28 | 2 | CID000003571 | |
| Drug | acetate | 7.38e-04 | 599 | 28 | 5 | CID000000175 | |
| Drug | R625 | 7.52e-04 | 33 | 28 | 2 | CID000072375 | |
| Drug | p-nitrophenyl | 7.52e-04 | 146 | 28 | 3 | CID000007416 | |
| Drug | MS-275 | 7.98e-04 | 149 | 28 | 3 | CID000004261 | |
| Drug | hexafluorophosphate | 7.99e-04 | 34 | 28 | 2 | CID000009886 | |
| Drug | norspermine | 7.99e-04 | 34 | 28 | 2 | CID000078350 | |
| Drug | Rhodium | 7.99e-04 | 34 | 28 | 2 | CID000023948 | |
| Drug | PNPC | 8.46e-04 | 35 | 28 | 2 | CID000165125 | |
| Drug | AC1OAH4D | 8.95e-04 | 36 | 28 | 2 | CID006857719 | |
| Drug | BCDs | 9.46e-04 | 37 | 28 | 2 | CID000364214 | |
| Drug | L-365,260 | 9.46e-04 | 37 | 28 | 2 | CID000104929 | |
| Drug | maltohexaose | 1.05e-03 | 39 | 28 | 2 | CID000439606 | |
| Drug | 7-OH-DPAT | 1.05e-03 | 39 | 28 | 2 | CID000001219 | |
| Drug | maltoheptose | 1.11e-03 | 40 | 28 | 2 | CID003037125 | |
| Drug | FR 4 | 1.11e-03 | 40 | 28 | 2 | CID005288243 | |
| Drug | compound 21 | 1.11e-03 | 40 | 28 | 2 | CID005312128 | |
| Drug | HFIP | 1.11e-03 | 40 | 28 | 2 | CID000013529 | |
| Disease | alpha-amylase 1 measurement | 2.89e-05 | 9 | 27 | 2 | EFO_0801371 | |
| Disease | alopecia areata (is_marker_for) | 3.61e-05 | 10 | 27 | 2 | DOID:986 (is_marker_for) | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 2.79e-04 | 27 | 27 | 2 | C1112155 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 3.22e-04 | 29 | 27 | 2 | C1333990 | |
| Disease | acute lymphoblastic leukemia (is_marker_for) | 4.44e-04 | 34 | 27 | 2 | DOID:9952 (is_marker_for) | |
| Disease | cervix uteri carcinoma in situ (is_marker_for) | 6.79e-04 | 42 | 27 | 2 | DOID:8991 (is_marker_for) | |
| Disease | Gastrointestinal Stromal Sarcoma | 8.50e-04 | 47 | 27 | 2 | C3179349 | |
| Disease | Gastrointestinal Stromal Tumors | 9.61e-04 | 50 | 27 | 2 | C0238198 | |
| Disease | pulmonary hypertension (is_marker_for) | 1.57e-03 | 64 | 27 | 2 | DOID:6432 (is_marker_for) | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 1.98e-03 | 72 | 27 | 2 | DOID:9744 (is_marker_for) | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 3.56e-03 | 97 | 27 | 2 | EFO_0007878, EFO_0009458 | |
| Disease | pneumonia, COVID-19 | 4.79e-03 | 113 | 27 | 2 | EFO_0003106, MONDO_0100096 | |
| Disease | Polydactyly | 5.13e-03 | 117 | 27 | 2 | C0152427 | |
| Disease | Squamous cell carcinoma | 5.74e-03 | 124 | 27 | 2 | C0007137 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YKEDNYVIMTTAHKE | 61 | Q96DZ1 | |
| EYVKYKYAMDEADEK | 61 | Q8WXK1 | |
| DLKANAEYIKMADHY | 161 | Q13085 | |
| EKDYVRSKIAEYMNH | 186 | P19961 | |
| MKDYDELLKYYELHE | 1 | Q14680 | |
| EKDYVRSKIAEYMNH | 186 | P04746 | |
| ASEYKYVVKHKMENE | 146 | Q12913 | |
| QKPYDDDAEYMKHTR | 1151 | Q13045 | |
| KRTEMEYYTHEKQEK | 691 | Q5T3J3 | |
| AEEMTKYHSDDYIKF | 61 | Q13547 | |
| KIYYIHTADDEVKMD | 1491 | Q5SZK8 | |
| HKSKYRDDMVKDDYE | 326 | Q5JVS0 | |
| KDTSKDKFDYIAYMD | 421 | P31512 | |
| DLAITMYKKHKLYDD | 1001 | Q9UG01 | |
| NKKKKRMDYYDSEHH | 566 | O43252 | |
| SDYKKDMVEGDKYWH | 761 | Q9BWV1 | |
| MKLRDEEYEKFSKHY | 206 | Q5THR3 | |
| SEKVDDYEHAAKYMK | 431 | O43148 | |
| TAEEMTKYHSDEYIK | 61 | Q92769 | |
| MKYYTSKINSHEDLE | 71 | P54277 | |
| DAQEHIYKLMKSDSY | 421 | P49802 | |
| SQDKIYNSYMDKDEH | 71 | Q8NB59 | |
| AKEVEHYKYELLKAM | 816 | Q7Z7L1 | |
| KDKEMYHDYICQYKE | 106 | Q8N1H7 | |
| EHFYKETMKNEYKEL | 121 | Q7RTR0 | |
| EKATDDYHYEKFKKM | 271 | Q9NZ63 | |
| DFEEFMKYLKDHEKK | 76 | Q6NUK1 | |
| TESEYYAKEIHKFDM | 96 | P10600 | |
| CMVHTAEKLYKSEKY | 276 | Q9UK12 |